Akèy › Kansè Endomèt › Kalifòni › Irvine
Etid klinik pou Kansè Endomèt nan Irvine, CA
9 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Irvine (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Ap rekriteFaz 1/2
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Ap rekriteFaz 3
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Ap rekriteFaz 1/2
- City of Hope, Irvine, Irvine
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Ap rekriteFaz 3
- Kaiser Permanente SoCal, Irvine
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Ap rekriteFaz 3
- Research Site, Irvine
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Ap rekriteFaz 1/2
- Research Site, Irvine
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Ap rekrite
- City of Hope at Irvine Lennar, Irvine
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Ap rekriteFaz 1
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Irvine
Etid Kansè Endomèt nan lòt vil
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Chicago, IL25 etid
- Columbus, OH25 etid
- Queens, NY25 etid
Lòt etid nan Irvine
- Kansè Poumon ki pa ti selil25 etid
- Kansè nan tete23 etid
- Kansè (tout kalite)16 etid
- Kansè Metastatik16 etid
- Kansè poumon15 etid
- Myelom Miltip14 etid
- Kansè pwostat14 etid
- Kansè ovè12 etid
- Maladi Alzheimer11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè vejik11 etid
- Kansè kolorektal10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.